Skip to main content

Table 1 Patient demographics and baseline characteristics for study samples ≤5 years old

From: Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma

Demographic

Cases (N = 335)

Ethnicity

 

 African American

4.8%

 Caucasian

39.7%

 Other

8.4%

 Unknown

47.2%

Age at surgery, years

 

 ≤65

25.1%

 >65

74.9%

Sex

 

 Female

27.8%

 Male

72.2%

Histology

 

 Non-urothelial carcinomaa

3.3%

 Urothelial carcinoma

97.6%

Stage

 

 0a

10.1%

 I

13.7%

 II

37.0%

 III

31.0%

 IIIB

0.3%

 IV

7.8%

Grade

 

 High

77.7%

 Low

22.1%

 Unknown

0.3%

Sample type

 

 Biopsy

0.3%

 Cystectomy

29.2%

 TURBT

69.6%

 Unknown

0.9%

  1. a Non-urothelial bladder cancer samples included in the analysis are further defined in Additional file 1
  2. TURBT transurethral resection of bladder tumor